Clinical Trials Browser

Has results × Hodgkin Disease × atezolizumab × Clear all

NCT03120676 2019-11-14

Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma

Phase 2 Terminated

3 enrolled 3 charts

Hodgkin Disease, Recurrence